Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138496428> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2138496428 endingPage "i77" @default.
- W2138496428 startingPage "i75" @default.
- W2138496428 abstract "Arthritis is an autoantibody-driven disease. Anti-CD20 treatment, removing B cells, treats the disease but introduces a new problem. This treatment removes B cells irrespective of their specificity, and thus attenuates the humoral response which might result in impaired immunity. Since it is impossible to specifically target the autoantigen-specific B cells, therapeutic strategies are generally directed to downstream targets such as the effector cytokines interleukin 1 (IL-1) and tumour necrosis factor α (TNFα). It has already been shown that blocking these cytokines using specific antibodies (anti-TNF), antagonists (IL-1 receptor (IL-1R) antagonist) or soluble receptors (TNFR) decreases disease severity. To date, interference with the TNF pathway has been shown to be very effective and is used successfully in the clinic. However, the development and production of large amounts of specific antibodies and inhibiting proteins such as antagonists or soluble receptors for clinical use is complex and very expensive. In addition, induction of antibody responses against several of these artificial proteins reduces their efficacy. There is therefore still a need for alternative therapeutics directed more specifically at these effector cytokines and other targets that can be used individually or in combination with other therapeutics. Although the strong therapeutic effect of inhibiting the IL-1 pathway shown in mice has not so far been confirmed in humans, it cannot be excluded that inhibition of the IL-1 signaling pathway will be effective in combination therapy including other targets. Moreover, IL-1 inhibition might be an effective therapy in the many other inflammatory and autoimmune diseases in which this cytokine is known to play an important role.IL-1 receptor accessory protein (IL-1RAcP) is a subunit of the IL-1R complex required for the stabilisation of the IL-1 and …" @default.
- W2138496428 created "2016-06-24" @default.
- W2138496428 creator A5005425930 @default.
- W2138496428 creator A5016836718 @default.
- W2138496428 creator A5026121576 @default.
- W2138496428 creator A5029017753 @default.
- W2138496428 creator A5033643112 @default.
- W2138496428 creator A5046864809 @default.
- W2138496428 creator A5051077458 @default.
- W2138496428 creator A5068620784 @default.
- W2138496428 date "2012-03-28" @default.
- W2138496428 modified "2023-10-02" @default.
- W2138496428 title "Antisense oligonucleotide mediated exon skipping as a potential strategy for the treatment of a variety of inflammatory diseases such as rheumatoid arthritis" @default.
- W2138496428 cites W137375139 @default.
- W2138496428 cites W1978388370 @default.
- W2138496428 cites W1991928630 @default.
- W2138496428 cites W2012055659 @default.
- W2138496428 cites W2149543855 @default.
- W2138496428 cites W2187961447 @default.
- W2138496428 doi "https://doi.org/10.1136/annrheumdis-2011-200971" @default.
- W2138496428 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22460143" @default.
- W2138496428 hasPublicationYear "2012" @default.
- W2138496428 type Work @default.
- W2138496428 sameAs 2138496428 @default.
- W2138496428 citedByCount "6" @default.
- W2138496428 countsByYear W21384964282013 @default.
- W2138496428 countsByYear W21384964282014 @default.
- W2138496428 countsByYear W21384964282016 @default.
- W2138496428 countsByYear W21384964282017 @default.
- W2138496428 countsByYear W21384964282021 @default.
- W2138496428 crossrefType "journal-article" @default.
- W2138496428 hasAuthorship W2138496428A5005425930 @default.
- W2138496428 hasAuthorship W2138496428A5016836718 @default.
- W2138496428 hasAuthorship W2138496428A5026121576 @default.
- W2138496428 hasAuthorship W2138496428A5029017753 @default.
- W2138496428 hasAuthorship W2138496428A5033643112 @default.
- W2138496428 hasAuthorship W2138496428A5046864809 @default.
- W2138496428 hasAuthorship W2138496428A5051077458 @default.
- W2138496428 hasAuthorship W2138496428A5068620784 @default.
- W2138496428 hasConcept C104317684 @default.
- W2138496428 hasConcept C129312508 @default.
- W2138496428 hasConcept C194583182 @default.
- W2138496428 hasConcept C203014093 @default.
- W2138496428 hasConcept C2777575956 @default.
- W2138496428 hasConcept C2778776201 @default.
- W2138496428 hasConcept C36823959 @default.
- W2138496428 hasConcept C54355233 @default.
- W2138496428 hasConcept C60644358 @default.
- W2138496428 hasConcept C71924100 @default.
- W2138496428 hasConcept C86803240 @default.
- W2138496428 hasConceptScore W2138496428C104317684 @default.
- W2138496428 hasConceptScore W2138496428C129312508 @default.
- W2138496428 hasConceptScore W2138496428C194583182 @default.
- W2138496428 hasConceptScore W2138496428C203014093 @default.
- W2138496428 hasConceptScore W2138496428C2777575956 @default.
- W2138496428 hasConceptScore W2138496428C2778776201 @default.
- W2138496428 hasConceptScore W2138496428C36823959 @default.
- W2138496428 hasConceptScore W2138496428C54355233 @default.
- W2138496428 hasConceptScore W2138496428C60644358 @default.
- W2138496428 hasConceptScore W2138496428C71924100 @default.
- W2138496428 hasConceptScore W2138496428C86803240 @default.
- W2138496428 hasIssue "Suppl 2" @default.
- W2138496428 hasLocation W21384964281 @default.
- W2138496428 hasLocation W21384964282 @default.
- W2138496428 hasOpenAccess W2138496428 @default.
- W2138496428 hasPrimaryLocation W21384964281 @default.
- W2138496428 hasRelatedWork W1969936400 @default.
- W2138496428 hasRelatedWork W2086178637 @default.
- W2138496428 hasRelatedWork W2093994633 @default.
- W2138496428 hasRelatedWork W2107496826 @default.
- W2138496428 hasRelatedWork W2142031680 @default.
- W2138496428 hasRelatedWork W2401719720 @default.
- W2138496428 hasRelatedWork W2443532808 @default.
- W2138496428 hasRelatedWork W2592499765 @default.
- W2138496428 hasRelatedWork W2987954841 @default.
- W2138496428 hasRelatedWork W3128892442 @default.
- W2138496428 hasVolume "71" @default.
- W2138496428 isParatext "false" @default.
- W2138496428 isRetracted "false" @default.
- W2138496428 magId "2138496428" @default.
- W2138496428 workType "article" @default.